Last Posted: Jan 03, 2019
- Association between genetic polymorphisms of CYP2C9 and VKORC1 and safety and efficacy of warfarin: Results of a 5 years audit.
Biswas Mansij et al. Indian heart journal 2018 Dec 70 Suppl 3S13-S19 - Fetal congenital heart disease: Associated anomalies, identification of genetic anomalies by single-nucleotide polymorphism array analysis, and postnatal outcome.
Cai Meiying et al. Medicine 2018 Dec 97(50) e13617 - Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiography.
Lukács Krogager Maria et al. PloS one 2018 13(12) e0208645 - Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomised waiting list controlled open-label study protocol.
Nomura Akihiro et al. BMJ open 2018 Dec 8(12) e023636 - Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning.
Dogan Meeshanthini V et al. Genes 2018 Dec 9(12) - Is Heart Disease Genetic?
L Meyers, Genome Medical, December 2018 - How Online Family History Tool Design and Message Content Impact User Perceptions: An Examination of Family HealthLink.
Thomas Sarah N et al. Public health genomics 2018 Dec 1-14 - How well can familial hypercholesterolemia be identified in an electronic health record database?
Mues Katherine E et al. Clinical epidemiology 2018 101667-1677 - Prevalence of Noonan spectrum disorders in a pediatric population with valvar pulmonary stenosis.
Anderson Kailyn et al. Congenital heart disease 2018 Dec - Vascular endothelial growth factor gene transfer therapy for coronary artery disease: A systematic review and meta-analysis.
Yuan Rong et al. Cardiovascular therapeutics 2018 Oct 36(5) e12461
.png)
No hay comentarios:
Publicar un comentario